Therapeutic effects of psyllium in type 2 diabetic patients

被引:86
作者
Sierra, M [1 ]
García, JJ [1 ]
Fernández, N [1 ]
Diez, MJ [1 ]
Calle, AP [1 ]
机构
[1] Univ Leon, Dept Pharmacol Toxicol & Nursing, E-24071 Leon, Spain
关键词
type 2 diabetic patients; ispaghula husk; psyllium; dietary fibre; glucose; insulin; cholesterol; capillary blood glucose; metabolic variables;
D O I
10.1038/sj.ejcn.1601398
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objective: The aim of this study was to evaluate the effects of psyllium in type 2 diabetic patients. Design: The study included three phases: phase I (I week), phase 2 (treatment, 14g fibre/day, 6 weeks) and phase 3 (4 weeks). At the end of each phase a clinical evaluation was performed after the ingestion of a test breakfast of 1824.2kJ (436 kcal). Measurements included concentrations of blood glucose, insulin, fructosamine, GHbA(1c), C-pepticle and 24h urinary glucose excretion. In addition, uric acid, cholesterol and several mineral and vitamin concentrations were also evaluated. Setting: The study was performed at the Department of Pharmacology, Toxicology and Nursing at the University of Leon (Spain). Subjects: Twenty type 2 diabetic patients (112 men and 8 women) participated in the study with a mean age of 67.4y for men and 66y for women. The mean body mass index of men was 28.2 kg/m(2) and that of women 25.9kg /m(2). Results: Glucose absorption decreased significantly in the presence of psyllium (12.2%); this reduction is not associated with an important change in insulin levels (5%). GHbA(1c), C-pepticle and 24h urinary glucose excretion decreased (3.8, 14.9 and 22.5%, respectively) during the treatment with fibre (no significant differences) as well as fructosamine (10.9%, significant differences). Psyllium also reduced total and LDL cholesterol (7.7 and 9.2%, respectively, significant differences), and uric acid (10%, significant difference). Minerals and vitamins did not show important changes, except sodium that increased significantly after psyllium administration. Conclusions: The results obtained indicate a beneficial therapeutic effect of psyllium (Plantabe(R)) in the metabolic control of type 2 diabetics as well as in lowering the risk of coronary heart disease. We also conclude that consumption of this fibre does not adversely affect either mineral or vitamin A and E concentrations. Finally, for a greater effectiveness, psyllium treatment should be individually evaluated.
引用
收藏
页码:830 / 842
页数:13
相关论文
共 65 条
[11]  
CARROLL DG, 1981, NEW ZEAL MED J, V93, P292
[12]  
Chuang L M, 1992, J Formos Med Assoc, V91, P15
[13]   Long-term effects of consuming foods containing psyllium seed husk on serum lipids in subjects with hypercholesterolemia [J].
Davidson, MH ;
Maki, KC ;
Kong, JC ;
Dugan, LD ;
Torri, SA ;
Hall, HA ;
Drennan, KB ;
Anderson, SM ;
Fulgoni, VL ;
Saldanha, LG ;
Olson, BH .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1998, 67 (03) :367-376
[14]   MEASUREMENT OF VITAMIN-A AND VITAMIN-E IN HUMAN-SERUM BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
DRISKELL, WJ ;
NEESE, JW ;
BRYANT, CC ;
BASHOR, MM .
JOURNAL OF CHROMATOGRAPHY, 1982, 231 (02) :439-444
[15]   GLUCOSE AND LIPID-METABOLISM AND INSULIN SENSITIVITY IN TYPE-1 DIABETES - THE EFFECT OF GUAR GUM [J].
EBELING, P ;
YKIJARVINEN, H ;
ARO, A ;
HELVE, E ;
SINISALO, M ;
KOIVISTO, VA .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1988, 48 (01) :98-103
[16]   BLOOD-GLUCOSE, PLASMA-INSULIN AND SENSORY RESPONSES TO GUAR-CONTAINING WHEAT BREADS - EFFECTS OF MOLECULAR-WEIGHT AND PARTICLE-SIZE OF GUAR GUM [J].
ELLIS, PR ;
DAWOUD, FM ;
MORRIS, ER .
BRITISH JOURNAL OF NUTRITION, 1991, 66 (03) :363-379
[17]   INVITRO INHIBITION OF RAT INTESTINAL SURFACE HYDROLYSIS OF DISACCHARIDES AND DIPEPTIDES BY GUARAN [J].
ELSENHANS, B ;
SUFKE, U ;
BLUME, R ;
CASPARY, WF .
DIGESTION, 1981, 21 (02) :98-103
[18]  
ELSENHANS B, 1984, GASTROENTEROLOGY, V86, P645
[19]   THE INFLUENCE OF CARBOHYDRATE GELLING AGENTS ON RAT INTESTINAL TRANSPORT OF MONOSACCHARIDES AND NEUTRAL AMINO-ACIDS INVITRO [J].
ELSENHANS, B ;
SUFKE, U ;
BLUME, R ;
CASPARY, WF .
CLINICAL SCIENCE, 1980, 59 (05) :373-380
[20]  
FAGERBERG SE, 1982, CURR THER RES CLIN E, V31, P166